Why Tenet Healthcare Corporation (THC) stock moved
Tenet Healthcare Corporation (THC) shares rose 0.8% to $270.57 as of October 29, 2026, a slight gain from the prior close of $268.50. BestStocks flagged the session as a major change for THC. The move is tied to an earnings beat. Below, we break down what changed for THC, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Earnings Beat
Tenet Healthcare Corporation (THC) reported EPS of $6.64 vs. $4.68 consensus estimate, beating by 41.9% on 2026-10-29. Monitor THC's next quarterly results and any guidance updates for confirmation of sustained earnings strength.
What it means for Tenet Healthcare Corporation investors
For Tenet Healthcare Corporation investors, the balance of recent signals points to a bullish shift. On the constructive side: Earnings beat with positive market reaction; Positive 0.8% session move. Weighing against that: Tenet Healthcare reported Q3 2026 earnings that topped consensus estimates and raised its 2026 financial outlook, per Business Wire and Zacks; Tenet Healthcare Corporation (THC) moved -5.71% from $194.81 to $183.69 on 2026-07-14. Wall Street's consensus price target sits at $288.00, implying +6.4% upside from $270.57. BestStocks rates the overall signal quality low (57/100). With earnings roughly 105 days out, the next report is the most likely near-term test of the move.
THC price reaction
THC last traded at $270.57, up $2.07 (+0.77%) from the previous close of $268.50. The session traded on 1.6× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $253.97 and $275.13, and it currently sits about 78% of the way up that band.
Bullish and bearish analyst opinions on Tenet Healthcare Corporation (THC)
The consensus analyst price target on Tenet Healthcare Corporation (THC) is $288.00, 6.4% above the recent $270.57. Over the past 90 days analysts logged 0 upgrades, 3 maintains, and 0 downgrades. Here is how the bullish and bearish cases on THC line up.
The bullish case
- Wall Street's consensus price target of $288.00 implies +6.4% upside from $270.57.
- The Street's most bullish target is $308.00 (+13.8%).
- Earnings beat with positive market reaction.
- Positive 0.8% session move.
- Positive price momentum.
The bearish case
- The most bearish analyst target is $265.00 (-2.1%).
- Tenet Healthcare reported Q3 2026 earnings that topped consensus estimates and raised its 2026 financial outlook, per Business Wire and Zacks.
- Tenet Healthcare Corporation (THC) moved -5.71% from $194.81 to $183.69 on 2026-07-14.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 29, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for THC
Frequently asked questions about THC
Why did Tenet Healthcare Corporation (THC) stock move?
THC rose 0.8% to $270.57. The move is associated with an earnings beat.
How much did THC stock rise?
THC gained 0.77% ($2.07) versus the prior close of $268.50, last trading at $270.57 on 1.6× average volume.
When is Tenet Healthcare Corporation's next earnings date?
THC's next earnings report is estimated for 2027-02-11 — about 105 days away.
What is the analyst price target for THC?
The consensus analyst price target for THC is $288.00, about 6.4% above the current $270.57. Over the past 90 days, analysts recorded 0 upgrades, 3 maintains, and 0 downgrades.
How BestStocks tracks THC
This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 20 tracked change events for THC, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 29, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.